期刊文献+

HPLC-MS-MS法定量测定人血浆中多潘立酮的浓度 被引量:8

Quantitative determination of domperidone in human plasma by high performance liquid chromatography-tandem mass spectrometry
在线阅读 下载PDF
导出
摘要 目的:建立HPLC-MS-MS方法定量测定人血浆中多潘立酮浓度。方法:以地西泮为内标,采用甲醇:0.5%乙酸=80:20为流动相,以Inerstil C18(2.1mm×100mm,3.0μm)色谱柱为分析柱,通过电喷雾离子源(ESI),以正离子多反应监测(MRM)方式进行检测。多潘立酮和地西泮用于定量分析的离子对分别为[M+H]+m/z426.2→m/z175.2和[M+H]+m/z285.0→m/z193.0。结果:多潘立酮线性范围为1~80μg·L-1,定量下限为1μg·L-1(n=6)。日内、日间的RSD均<15%,平均回收率>75%。结论:本方法专属性强,样品处理方便,灵敏度高,适用于多潘立酮临床药动学研究。 Objective:To establish a HPLC-MS-MS method for the determination of domperidone in human plasma.Methods:Diazepam was used as internal standard.Domperidone was separated on an Inerstil C18 column(2.1 mm×100 mm,3.0 μm).The mobile phase consisted of methanol -0.5% acetic acid(80 :20).Electrospray ionization(ESI) was applied and operated in the positive multiple reaction monitoring(MRM) mode,used the transitions of [M + H]^ + m/z 426.2 → m/z 175.2 and [M + H]^+ m/z 285.0 → m/z 193.0 to quantify domperidone and the internal standard respectively.Results:The linear calibration curve was obtained over the concentration range of 1 ~ 80 μg · L ^-1.The limit of quantification was 1 μg · L ^-1(n = 6).The inter and intra-day precision(RSD) were less than 15%.The average recovery was above 75%.Conclusion:The method is proved to be specific,convenient,sensitive and suitable for the clinical investigation of domperidone pharmacokinetics.
出处 《中国药物应用与监测》 CAS 2008年第5期19-21,共3页 Chinese Journal of Drug Application and Monitoring
关键词 多潘立酮 液相色谱-质谱联用法 血浆药物浓度 Domperidone HPLC-MS-MS Plasma concentration
  • 相关文献

参考文献3

二级参考文献14

  • 1-.吗丁啉药品介绍[J].中国医院药学杂志,1989,9(2):55-55.
  • 2Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24: 360-400.
  • 3Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R.Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000; 54:458 -62.
  • 4Andreu N, Chale JJ, Senard JM, Thalamas C, Montaswac JL, Rascol O. L-Dopa-induced sedation: a double-blind Cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999; 22: 15-23.
  • 5Galvez-Jimenez N, Lang AE. Perioperative problems in Parkinson's disease and their management: apomorphine with rectal domperidone. Cart J Neurol Sci 1996; 23: 198 - 203.
  • 6Smith L, De Salvia M, Jenner P, Marsden CD. An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1, 2, 3, 0-tetrahydropyridine-treated common marmosets. Mov Disord 1996; 11: 125-35.
  • 7Heykants J, Knaeps A, Meuldermans W, Michiels M. On the pharmacokinetics of dompridone in animals and than. Ⅰ.Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in rats.Eur J Drug Metab Phannacokinet 1961;6 : 27 - 36.
  • 8Huang YC, Colaizzi JL, Bierman RH, Woestenborghs R,Heykants J. Pharmacokinetics and dose proportionality of domperidone in healthy volunteers. J Clin Pharmaool 1986;26: 628-32.
  • 9Yamanoto. K, Hagino M, Kotaki H, lga T. Quantitative determination of domperidone in rat plasma by high-performance liguid chromatography with fluorescence detection.J Chromatogr B Biomed Sci Appl 1998; 720:251 - 5.
  • 10Michiels M, Hendriks R, Hykants J. On the pharmacokinetics of domperidone in animals and man. Ⅱ. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat. Eur J Drug Metab Pharmacokinet 1961;6:37 - 48.

共引文献10

同被引文献72

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部